106 related articles for article (PubMed ID: 1718957)
1. Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase.
Herbst R; Lammers R; Schlessinger J; Ullrich A
J Biol Chem; 1991 Oct; 266(30):19908-16. PubMed ID: 1718957
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of W mutations on p145c-kit tyrosine kinase activity and substrate interaction.
Herbst R; Shearman MS; Obermeier A; Schlessinger J; Ullrich A
J Biol Chem; 1992 Jul; 267(19):13210-6. PubMed ID: 1377679
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine 785 is a major determinant of Trk--substrate interaction.
Obermeier A; Halfter H; Wiesmüller KH; Jung G; Schlessinger J; Ullrich A
EMBO J; 1993 Mar; 12(3):933-41. PubMed ID: 8384556
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C.
Blume-Jensen P; Rönnstrand L; Gout I; Waterfield MD; Heldin CH
J Biol Chem; 1994 Aug; 269(34):21793-802. PubMed ID: 7520444
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.
Reith AD; Ellis C; Lyman SD; Anderson DM; Williams DE; Bernstein A; Pawson T
EMBO J; 1991 Sep; 10(9):2451-9. PubMed ID: 1714377
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
Jallal B; Schlessinger J; Ullrich A
J Biol Chem; 1992 Mar; 267(7):4357-63. PubMed ID: 1347042
[TBL] [Abstract][Full Text] [Related]
7. Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro.
Herbst R; Shearman MS; Jallal B; Schlessinger J; Ullrich A
Biochemistry; 1995 May; 34(17):5971-9. PubMed ID: 7537096
[TBL] [Abstract][Full Text] [Related]
8. A specific combination of substrates is involved in signal transduction by the kit-encoded receptor.
Lev S; Givol D; Yarden Y
EMBO J; 1991 Mar; 10(3):647-54. PubMed ID: 1705885
[TBL] [Abstract][Full Text] [Related]
9. A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses.
Lev S; Yarden Y; Givol D
J Biol Chem; 1992 May; 267(15):10866-73. PubMed ID: 1375232
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase.
Miyazawa K; Hendrie PC; Mantel C; Wood K; Ashman LK; Broxmeyer HE
Exp Hematol; 1991 Dec; 19(11):1110-23. PubMed ID: 1721591
[TBL] [Abstract][Full Text] [Related]
11. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
Liu SM; Carpenter G
J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
[TBL] [Abstract][Full Text] [Related]
12. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene.
Lev S; Yarden Y; Givol D
Mol Cell Biol; 1990 Nov; 10(11):6064-8. PubMed ID: 1700279
[TBL] [Abstract][Full Text] [Related]
13. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells.
Nakamura N; Chin H; Miyasaka N; Miura O
J Biol Chem; 1996 Aug; 271(32):19483-8. PubMed ID: 8702638
[TBL] [Abstract][Full Text] [Related]
14. Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase.
Burgess WH; Dionne CA; Kaplow J; Mudd R; Friesel R; Zilberstein A; Schlessinger J; Jaye M
Mol Cell Biol; 1990 Sep; 10(9):4770-7. PubMed ID: 2167438
[TBL] [Abstract][Full Text] [Related]
15. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
[TBL] [Abstract][Full Text] [Related]
16. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein.
Duronio V; Welham MJ; Abraham S; Dryden P; Schrader JW
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1587-91. PubMed ID: 1371879
[TBL] [Abstract][Full Text] [Related]
17. Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo.
Kozutsumi H; Toyoshima H; Hagiwara K; Yazaki Y; Hirai H
Oncogene; 1994 Oct; 9(10):2991-8. PubMed ID: 8084603
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
Riedel H
J Virol; 1994 Jan; 68(1):411-24. PubMed ID: 8254751
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt.
Wick MJ; Dong LQ; Hu D; Langlais P; Liu F
J Biol Chem; 2001 Nov; 276(46):42843-50. PubMed ID: 11551902
[TBL] [Abstract][Full Text] [Related]
20. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden Y; Kuang WJ; Yang-Feng T; Coussens L; Munemitsu S; Dull TJ; Chen E; Schlessinger J; Francke U; Ullrich A
EMBO J; 1987 Nov; 6(11):3341-51. PubMed ID: 2448137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
